Arthroscopic management of unexplained pain following total knee arthroplasty
Introduction Arthrofibrosis develops in 3–10% of knees after total knee arthroplasty (TKA), which may result in pain and restricted range-of-motion. Treatment options include manipulation under anaesthesia, arthroscopic debridement, and quadricepsplasty, but there is little consensus on their effica...
Gespeichert in:
Veröffentlicht in: | Archives of orthopaedic and trauma surgery 2022-06, Vol.142 (6), p.1109-1115 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Introduction
Arthrofibrosis develops in 3–10% of knees after total knee arthroplasty (TKA), which may result in pain and restricted range-of-motion. Treatment options include manipulation under anaesthesia, arthroscopic debridement, and quadricepsplasty, but there is little consensus on their efficacy for treatment of unexplained pain after TKA. The purpose of this study was to report the prevalence and characteristics of unexplained pain after TKA as revealed by arthroscopic exploration, and assess the efficacy of arthroscopic procedures to relieve pain.
Materials and methods
From a consecutive series of 684 TKAs, 11 patients (1.6%) had unexplained pain at 7–48 months after TKA. Causes of pain remained unidentified after systematic and differential assessment, but arthroscopic exploration revealed fibrotic tissues, which were debrided during the same procedure. Patients were assessed first at 6–61 months and last at 90–148 months, with pain on a visual analog scale (pVAS) and range-of-motion recorded during both assessments, but Oxford Knee Score (OKS) and Forgotten Joint Score (FJS) only during the last assessment. Residual pain was classified as little or no pain (pVAS, 0–1), moderate pain (pVAS, 2–4), and severe pain (pVAS, 5–10).
Results
At first follow-up (
n
= 11) pVAS improved by 4.1 ± 1.1 (
p
|
---|---|
ISSN: | 1434-3916 0936-8051 1434-3916 |
DOI: | 10.1007/s00402-021-03924-x |